CD163 and acute myeloid leukemia: Additionally, monocyte-like AML cells effectively suppress T-cell activation by expressing a series of immunomodulatory genes, such as antigen-presenting components MRC1 and CD163, leading to altered T-cell phenotype and shaping an immunosuppressive AML microenvironment (11).